KANG [iKang Healthcare] 25-NSE: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]

KANG [iKang Healthcare] 25-NSE: .FormData {color: blue; background-color: white; font-size: small; font-family:

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]

KANG [iKang Healthcare] 6-K: iKang Announces Unaudited Financial Results for the Fiscal

[iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services mar]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services mar]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services mar]

KANG [iKang Healthcare] 6-K: iKang Announces Unaudited Financial Results for the Fiscal

[iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services mar]

KANG [iKang Healthcare] SC 13D/A: (Original Filing)

[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]

KANG [iKang Healthcare] SC 13D/A: SCHEDULE 13D iKang Healthcare Group, Inc. (Name of

[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]

Skip to toolbar